Published in Chem Biol Interact on February 25, 2006
Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle. J Virol (2006) 1.47
Coinfection of Chlamydia trachomatis, Ureaplasma urealyticum and human papillomavirus among patients attending STD clinics in Estonia. Scand J Infect Dis (2007) 1.43
A bovine papillomavirus-1 based vector restores the function of the low-density lipoprotein receptor in the receptor-deficient CHO-ldlA7 cell line. BMC Mol Biol (2002) 1.39
Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog (2009) 1.34
Analysis of chromatin attachment and partitioning functions of bovine papillomavirus type 1 E2 protein. J Virol (2004) 1.29
Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J (2007) 1.27
Papillomavirus DNA replication - from initiation to genomic instability. Virology (2009) 1.15
Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification. J Virol (2012) 1.14
Complex formation between hepatitis C virus NS2 and NS3 proteins. Virus Res (2005) 1.14
Predominance of a rare type of HIV-1 in Estonia. J Acquir Immune Defic Syndr (2005) 1.02
Association of bovine papillomavirus E2 protein with nuclear structures in vivo. J Virol (2005) 0.99
Association of cagA and vacA genotypes of Helicobacter pylori with gastric diseases in Estonia. J Clin Microbiol (2002) 0.98
Persistent immune responses induced by a human immunodeficiency virus DNA vaccine delivered in association with electroporation in the skin of nonhuman primates. Hum Gene Ther (2009) 0.97
Development of a cellular assay system to study the genome replication of high- and low-risk mucosal and cutaneous human papillomaviruses. J Virol (2011) 0.96
Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH. Viral Immunol (2005) 0.94
Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome. Virology (2010) 0.93
Construction, properties, and potential application of infectious plasmids containing Semliki Forest virus full-length cDNA with an inserted intron. J Virol Methods (2007) 0.92
Identification and analysis of papillomavirus E2 protein binding sites in the human genome. J Virol (2011) 0.90
Induction of the bovine papillomavirus origin "onion skin"-type DNA replication at high E1 protein concentrations in vivo. J Virol (2002) 0.90
Recombination-dependent oligomerization of human papillomavirus genomes upon transient DNA replication. J Virol (2013) 0.89
RIG-I and MDA-5 detection of viral RNA-dependent RNA polymerase activity restricts positive-strand RNA virus replication. PLoS Pathog (2013) 0.88
A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A-C subtypes and the ancestor sequence of the F-H subtypes. Preclinical and clinical studies. Microbes Infect (2005) 0.87
Mapping of betapapillomavirus human papillomavirus 5 transcription and characterization of viral-genome replication function. J Virol (2013) 0.85
Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU(®)-Multi-HIVB, in untreated HIV-1 infected subjects. Vaccine (2012) 0.85
Elicitation of broad CTL response against HIV-1 by the DNA vaccine encoding artificial multi-component fusion protein MultiHIV--study in domestic pigs. Vaccine (2009) 0.84
Episomal maintenance of plasmids with hybrid origins in mouse cells. J Virol (2005) 0.83
New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids. Biochim Biophys Acta (2013) 0.83
Presentation overrides specificity: probing the plasticity of alphaviral proteolytic activity through mutational analysis. J Virol (2013) 0.82
Functional characterization of fingers subdomain-specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem (2008) 0.81
Characterization of the functional activities of the bovine papillomavirus type 1 E2 protein single-chain heterodimers. J Virol (2006) 0.81
Bovine papillomavirus type 1 E2 protein heterodimer is functional in papillomavirus DNA replication in vivo. Virology (2009) 0.81
Effective formation of the segregation-competent complex determines successful partitioning of the bovine papillomavirus genome during cell division. J Virol (2010) 0.81
Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine. AIDS Res Hum Retroviruses (2006) 0.79
DNA Transfer into Animal Cells Using Stearylated CPP Based Transfection Reagent. Methods Mol Biol (2015) 0.78
Two separate replication modes of the bovine papillomavirus BPV1 origin of replication that have different sensitivity to p53. Virus Res (2003) 0.78
High prevalence of the CCR5Delta32 HIV-resistance mutation among Estonian HIV type 1-infected individuals. AIDS Res Hum Retroviruses (2007) 0.77
Characterization of the nuclear matrix targeting sequence (NMTS) of the BPV1 E8/E2 protein--the shortest known NMTS. Nucleus (2015) 0.75
A bovine papillomavirus-1 based vector restores the function of the low-density lipoprotein receptor in the receptor-deficient CHO-ldlA7 cell line: Correction. BMC Mol Biol (2002) 0.75
Identification of the immunodominant regions of the melanoma antigen tyrosinase by anti-tyrosinase monoclonal antibodies. Melanoma Res (2003) 0.75
CuZn-SOD suppresses the bovine papillomavirus-induced proliferation of fibroblasts. APMIS (2007) 0.75
Production of functional recombinant tyrosine hydroxylase by the BPV-1 expression plasmids in the cell cultures. Plasmid (2003) 0.75